Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 786 GBX 0.56% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Genus PLC?
Write Note

Genus PLC
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genus PLC
Operating Expenses Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Operating Expenses
-ÂŁ614.6m
CAGR 3-Years
-6%
CAGR 5-Years
-36%
CAGR 10-Years
-6%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Operating Expenses
-$178.1m
CAGR 3-Years
-157%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Operating Expenses
-ÂŁ167.1m
CAGR 3-Years
-91%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Operating Expenses
-$177.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Operating Expenses
-$233.4m
CAGR 3-Years
-45%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Operating Expenses
-ÂŁ308m
CAGR 3-Years
-37%
CAGR 5-Years
-21%
CAGR 10-Years
N/A

See Also

What is Genus PLC's Operating Expenses?
Operating Expenses
-614.6m GBP

Based on the financial report for Jun 30, 2024, Genus PLC's Operating Expenses amounts to -614.6m GBP.

What is Genus PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-6%

Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Genus PLC have been -6% over the past three years , -36% over the past five years , and -6% over the past ten years .

Back to Top